http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103143069-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c491d9293b8310179efca603a90298
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-204
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
filingDate 2006-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdcc39a123cbca1feca3211c60f332ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a1a2a838338d381ce325f5eeb45bba7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ea9645ca42bae2a6a9e1e62ff3d648a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e19438e37b1c563f0c9f6c224b6778d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d14402d672af264811bf19e816f9f5d
publicationDate 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103143069-A
titleOfInvention Drugs with improved hydrophobicity for incorporation into medical devices
abstract The present invention provides medical devices comprising hydrophobic analogs of drugs known to inhibit cell proliferation and migration. Examples of suitable drugs include, for example, geldanamycin antibiotics, colchicine, combretastatins, camptothecins, taxanes and rapamycin and analogs thereof. The drug may be incorporated into the device or coated on the device.
priorityDate 2005-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0154745-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5319112-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0101890-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419646300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77922

Total number of triples: 37.